Patents by Inventor Karen Neder

Karen Neder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CATIONIC CYCLIC AMINE AND AMPHIPATHIC TRANSFECTION REAGENTS
    Publication number: 20240026051
    Abstract: Cationic cyclic amine containing polymers and copolymers as well as novel lipids have been designed and synthesized for efficient delivery of nucleic acids to cells in biological systems, specifically for in vitro cell transfection research.
    Type: Application
    Filed: July 12, 2023
    Publication date: January 25, 2024
    Inventors: Nicholas A. A. Rossi, Anatoly Pinchuk, Karen Neder, James Ludtke, Laura Juckem
  • Cationic cyclic amine and amphipathic transfection reagents
    Patent number: 11739174
    Abstract: Cationic cyclic amine containing polymers and copolymers as well as novel lipids have been designed and synthesized for efficient delivery of nucleic acids to cells in biological systems, specifically for in vitro cell transfection research.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: August 29, 2023
    Assignee: Mirus Bio LLC
    Inventors: Nicholas A. A. Rossi, Anatoly Pinchuk, Karen Neder, James Ludtke, Laura Juckem
  • Transfection compositions using amphipathic compounds
    Patent number: 9290779
    Abstract: A low toxicity, highly efficient transfection composition is described with an amphipathic compound containing at least one imidazole. The composition may be used in the process of transfecting nucleic acids into an animal cell.
    Type: Grant
    Filed: June 15, 2014
    Date of Patent: March 22, 2016
    Inventors: Laura Juckem, Karen Neder, James Hagstrom, Jon Wolff
  • Novel quinones as disease therapies
    Publication number: 20050010060
    Abstract: Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.
    Type: Application
    Filed: August 2, 2004
    Publication date: January 13, 2005
    Applicant: SLIL BIOMEDICAL CORPORATION
    Inventors: Andrei Blokhin, Benjamin Frydman, Laurence Marton, Karen Neder, Jerry Sun
  • 4-substituted-1,2-naphthoquinones and their use in the inhibition of neoplastic cell growth
    Patent number: 5977187
    Abstract: Novel 4-substituted-1,2-naphthoquinones, pharmaceutical unit dosage forms containing 4-substituted-1,2-naphthoquinones, and uses of 4-substituted-1,2-naphthoquinones to inhibit the growth of cancer cells are disclosed.
    Type: Grant
    Filed: October 14, 1998
    Date of Patent: November 2, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Benjamin J. Frydman, Donald T. Witiak, Laurence J. Marton, Karen Neder, M. Eileen Dolan
  • 4-substituted-1, 2-naphthoquinones and their use in the inhibition of neoplastic cell growth
    Patent number: 5883270
    Abstract: Novel 4-substituted-1,2-naphthoquinones, pharmaceutical unit dosage forms containing 4-substituted-1,2-naphthoquinones, and uses of 4-substituted-1,2-naphthoquinones to inhibit the growth of cancer cells are disclosed.
    Type: Grant
    Filed: November 6, 1996
    Date of Patent: March 16, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Benjamin J. Frydman, Donald T. Witiak, Laurence J. Marton, Karen Neder, M. Eileen Dolan